- CH₣1.53bn
- CH₣1.60bn
- €391.95m
PolyPeptide slumps on FY miss
Brief: PolyPeptide Group FY Revenue At EUR 281.0 Mln
Polypeptide drops after CEO resignation
Brief: Polypeptide Group CEO Resigns
PolyPeptide soars after wins 100-million-euro annual deal
Brief: Polypeptide Signs Commercial Agreement
UBS ups PolyPeptide to 'neutral' as potential future challenges now look priced-in
Polypeptide slumps on another profit warning
Brief: Polypeptide Group Cuts 2022 Guidance
Europe Research Roundup: Colruyt NV, Metro AG, Thales
Europe Research Roundup: Clariant, Polypeptide Group, Volkswagen
Baader upgrades Polypeptide as share decline opens 'good entry point'
Swiss stocks - Factors to watch on September 30
Europe Research Roundup: Boliden AB, H&M, Uniper SE
PolyPeptide falls on earnings slump, outlook cut as costs bite
Brief: Polypeptide H1 EBITDA At EUR 26.7 Mln (H1 2021: EUR 43.2 Mln)
Europe Research Roundup: Dufry, Randstad, Teleperformance
Brief: Polypeptide Expects Drop In Profitability In H1 2022 Vs H1 2021
Swiss stocks - Factors to watch on March 15